Literature DB >> 9451037

Synthesis of neoglycoconjugates containing deaminated neuraminic acid (KDN) using rat liver alpha2,6-sialyltransferase.

T Angata1, T Matsuda, K Kitajima.   

Abstract

2-Keto-3-deoxy-D- glycero -D- galacto -nononic acid (KDN) was introduced into asialotransferrin and N -acetyllactosamine (LacNAc) from CMP-KDN by using rat liver Galbeta1-->4GlcNAc alpha2, 6-sialyltransferase to form KDN-transferrin and KDN-LacNAc. These structures contain terminal KDNalpha2-->6Gal-residues, a glycotope that has not yet been described in natural glycoconjugates. KDN was transferred to all four Gal residues in asialotransferrin by this enzyme. The incorporation efficiency of KDN from CMP-KDN into asialotransferrin was about half that of Neu5Ac from CMP-Neu5Ac, based on the V max/ K m values for these donor substrates, 0.0527 min-1and 0.119 min-1, respectively. The KDNalpha2-->6Gal linkage was resistant to exosialidase treatment, in contrast to the sensitivity of the Neu5Acalpha2-->6Gal linkage. Interestingly, Sambucus sieboldiana agglutinin (SSA) was shown to prefer KDN-transferrin to the corresponding Neu5Ac-transferrin, as estimated by slot-blot analysis. The use of an alpha2,6-sialyltransferase to synthesize neoglycoproteins containing KDN has not been previously reported. Their facile synthesis using CMP-KDN and sialyltransferases with different specificities offers new possibilities to study the function of neo-KDN-glycoconjugates, and to explore their use in glycotechnology.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9451037     DOI: 10.1093/glycob/8.3.277

Source DB:  PubMed          Journal:  Glycobiology        ISSN: 0959-6658            Impact factor:   4.313


  8 in total

1.  N-Terminal 112 amino acid residues are not required for the sialyltransferase activity of Photobacterium damsela alpha2,6-sialyltransferase.

Authors:  Mingchi Sun; Yanhong Li; Harshal A Chokhawala; Ryan Henning; Xi Chen
Journal:  Biotechnol Lett       Date:  2007-11-08       Impact factor: 2.461

2.  Oral ingestion of mannose alters the expression level of deaminoneuraminic acid (KDN) in mouse organs.

Authors:  Shinji Go; Chihiro Sato; Kimio Furuhata; Ken Kitajima
Journal:  Glycoconj J       Date:  2006-07       Impact factor: 2.916

Review 3.  KDN (deaminated neuraminic acid): dreamful past and exciting future of the newest member of the sialic acid family.

Authors:  Sadako Inoue; Ken Kitajima
Journal:  Glycoconj J       Date:  2006-07       Impact factor: 2.916

4.  Identification and partial characterization of soluble and membrane-bound KDN(deaminoneuraminic acid)-glycoproteins in human ovarian teratocarcinoma PA-1, and enhanced expression of free and bound KDN in cells cultured in mannose-rich media.

Authors:  Sadako Inoue; Geetha L Poongodi; Nimmagadda Suresh; Tschining Chang; Yasuo Inoue
Journal:  Glycoconj J       Date:  2006-07       Impact factor: 2.916

Review 5.  Sialic acid metabolism and sialyltransferases: natural functions and applications.

Authors:  Yanhong Li; Xi Chen
Journal:  Appl Microbiol Biotechnol       Date:  2012-04-13       Impact factor: 4.813

6.  Cloning and expression of human sialic acid pathway genes to generate CMP-sialic acids in insect cells.

Authors:  S M Lawrence; K A Huddleston; N Tomiya; N Nguyen; Y C Lee; W F Vann; T A Coleman; M J Betenbaugh
Journal:  Glycoconj J       Date:  2001-03       Impact factor: 2.916

Review 7.  Advanced Technologies in Sialic Acid and Sialoglycoconjugate Analysis.

Authors:  Ken Kitajima; Nissi Varki; Chihiro Sato
Journal:  Top Curr Chem       Date:  2015

8.  A point-mutation in the C-domain of CMP-sialic acid synthetase leads to lethality of medaka due to protein insolubility.

Authors:  Di Wu; Hiromu Arakawa; Akiko Fujita; Hisashi Hashimoto; Masahiko Hibi; Kiyoshi Naruse; Yasuhiro Kamei; Chihiro Sato; Ken Kitajima
Journal:  Sci Rep       Date:  2021-12-01       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.